MET and non-small cell lung carcinoma: Regardless of the mechanism involved, the presence of HGF in NSCLC tumours harbouring MET exon 14 skipping strongly indicates the presence of an HGF‐METex14 signalling axis in these patients, which may have a deep impact on a ligand‐dependent oncogene addiction.